FDA Grants Accelerated Approval to Sunvozertinib for Metastatic Non-Small Cell Lung Cancer with EGFR exon 20 Insertion Mutations By Ogkologos - July 25, 2025 69 0 Facebook Twitter Google+ Pinterest WhatsApp FDA also approved the Oncomine Dx Express Test as a companion diagnostic device Source RELATED ARTICLESMORE FROM AUTHOR FDA Approves Gemcitabine Intravesical System for Non-Muscle Invasive Bladder Cancer ESMO Calls for Robust EU Taxation of Tobacco Products, Aiming to Prevent Cancers Attributable to Tobacco Use EMA Recommends Granting a Marketing Authorisation for Biosimilar Pegfilgrastim MOST POPULAR For Some Women with Breast Cancer, Cost Influences Decisions about Surgery September 6, 2019 “Nothing about us without us”: Why we’re working in partnership with... March 10, 2023 Trial Establishes Preferred Treatment for Some People with Esophageal Cancer July 9, 2024 ScottishPower help us shine a light on air pollution and cancer December 9, 2021 Load more HOT NEWS Breast Cancer Patients With Anxiety or Depression More Prone to Opioid... How to Talk With Your Children About Your Metastatic Cancer Prognosis Interpreted cancer awareness workshops: talking about cancer with South-Asian communities How Breast Cancer Risk Assessment Tools Work
